Stay tuned for an in-depth discussion on navigating operational workflows and mitigating barriers to access for CAR T-cell therapy in multiple myeloma.
Exploring Practical CAR T Cell Use in Multiple Myeloma Care
Advertisement
Two hematologic oncology experts discuss operational and referral workflows, as well as barriers to access for CAR T-cell therapy in multiple myeloma.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Advisory Committee Backs RP1/Nivolumab for Advanced Melanoma
2
CAR T-Cell Therapy Could Soon Expand Into Non-Oncology Indications
3
How KRAS-Targeted Therapy May Advance Toward Cancer Prevention
4
Subcutaneous Amivantamab Receives FDA Priority Review in R/M HNSCC
5